Regeneron Pharmaceuticals, Inc.
Marion McCourt (EVP Commercial) sells REGN shares
AI-generated summary
Marion McCourt, EVP Commercial at Regeneron Pharmaceuticals, Inc., sold 1,132 shares of Common Stock on October 30, 2026, for an average price of $869.43, totaling $984,194.76. The sale was executed under a Rule 10b5-1 trading plan adopted on February 17, 2026. Following the transaction, the insider directly holds 10,871 shares.
Key facts
- Insider
- Marion McCourt · EVP Commercial
Rule 10b5-1 plan · adopted Feb 17, 2026
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Oct 30, 2026 | S · open-market saleFootnotes F1 | −1,132 | $869.43 | $984,194.76 | 10,871 | Direct |
Footnotes
- F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 17, 2026.
More REGN filings
- 4
Filed Nov 3, 2026
- 144
Filed Nov 3, 2026
- 4
Filed Nov 3, 2026
- 144
Filed Nov 2, 2026
- 144
Filed Nov 2, 2026
- 144
Filed Nov 2, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.